Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from NeuroBo Pharmaceuticals (NRBO) is now available.
NeuroBo Pharmaceuticals, Inc. has entered into an exclusive licensing agreement with MThera Pharma Co., Ltd. for the rights to NB-01, a treatment for painful diabetic neuropathy. The deal empowers MThera to conduct extensive research and potentially a Phase 3 clinical trial in the U.S. and South Korea. However, the press release also contains cautionary statements about forward-looking information, indicating that these projections are not assured and actual results could vary significantly.
Learn more about NRBO stock on TipRanks’ Stock Analysis page.